Skip to main content
. 2020 Apr 22;156(6):1–10. doi: 10.1001/jamadermatol.2020.0796

Figure 3. Forest Plots of Network Meta-analysis Results for Atopic Dermatitis Treatment Between 8 and 16 Weeks .

Figure 3.

A, Change in Eczema Area and Severity Index (EASI) score. B, The standardized mean difference (SMD) of change in signs of the disease among medications currently in use. C, Change in Patient-Oriented Eczema Measure (POEM) score. D, Change in Dermatology Life Quality Index (DLQI) score. Results for fevripitant are available only in clinical trial registries. The SEs given for the change in EASI score are very small and may be in error. If in fact these SEs are erroneous, they may have changed the precision of the effect estimates for comparisons with fevripirant. Each systemic medication is compared with placebo. Negative values represent improvement in the disease state.